Remixpoint
3825
Metaplanet
3350
FUJI Media Holdings
4676
4
SoftBank
9434
5
Nippon Telegraph & Telephone
9432
JP Stock MarketDetailed Quotes
4591 Ribomic
- 85
- +1+1.19%
20min DelayMarket Closed Jan 24 15:30 JST
3.55BMarket Cap-2.96P/E (Static)
86High83Low837.50KVolume83Open84Pre Close70.92MTurnover12352wk High2.22%Turnover Ratio41.73MShares6052wk Low-25.7EPS TTM3.21BFloat Cap2078Historical HighLossP/E (Static)37.71MShs Float60Historical Low-28.7EPS LYR3.57%Amplitude--Dividend TTM1.05P/B100Lot Size--Div YieldTTM
About Ribomic Company
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
Company Profile
Symbol4591
Company NameRibomic
Founded2003-08-01
MarketTSE Growth
Fiscal Year Ends03-31
Address3-16-13 Usui Building Shirokanedai, Minato-ku
Zip Code108-0071
Phone03-3440-3303
Websitewww.ribomic.com
Company Executives
- Name
- Position
- Salary
- Takeo Adachi
- Director and Executive Officer, Head of Research and Development Division and Head of Discovery Research Department
- --
- Hisato Ooiwa
- Director and Executive Officer, Head of Administration Division
- --
- Yoshikazu Nakamura
- Representative Director, President and Head of Business Promotion Headquarters
- --
- Toshinobu Fujiwara
- Independent Director
- --
- Toshiaki Nishihata
- Independent Director
- --
- Matsufuji Chiya
- Independent Director
- --